Loading organizations...
Evidence-based diagnostic tool for neurodegenerative diseases.
CND Life Sciences has raised $21.9M across 4 funding rounds.
CND Life Sciences has raised $21.9M in total across 4 funding rounds.
CND Life Sciences has raised $21.9M in total across 4 funding rounds.
CND Life Sciences's investors include Daniel Livschutz, Patrick Lee, Peter Harris, HonorHealth.
CND Life Sciences has raised $21.9M across 4 funding rounds. Most recently, it raised $13.5M Series A in May 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 14, 2025 | $13.5M Series A | Daniel Livschutz | |
| Apr 6, 2023 | $1.0M Seed Extension | Patrick Lee | |
| Feb 3, 2022 | $5.0M Seed | ||
| Mar 24, 2021 | $2.4M Seed | Peter Harris | HonorHealth |